Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Cancer Biomarkers · 2024-09 · 41 (1) · 1-24
DOI: 10.3233/cbm-230486 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Biomarkers, 2024-09. Verfasst von Xifeng Fei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplastic Stem Cells, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioma is the most common primary tumor of the central nervous system (CNS). Glioblastoma (GBM) is incurable with current treatment strategies. Additionally, the treatment of recurrent GBM (rGBM) is often referred to as terminal treatment, necessitating hospice-level care and management. The presence of the blood-brain barrier (BBB) gives GBM a more challenging or “cold” tumor microenvironment (TME) than that of other cancers and gloma stem cells (GSCs) play an important role in the TME remodeling, occurrence, development and recurrence of giloma. In this review, our primary focus will be on discussing the following topics: niche-associated GSCs and macrophages, new theories regarding GSC and TME involving pyroptosis and ferroptosis in GBM, metabolic adaptations of GSCs, the influence of the cold environment in GBM on immunotherapy, potential strategies to transform the cold GBM TME into a hot one, and the advancement of GBM immunotherapy and GBM models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu, China.
- Department of Neurosurgery, The Affiliated Suzhou Science and Technology Town Hospital of Nanjing University Medical School, Suzhou, Jiangsu, China.
- Department of GCP, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu, China.
- Pediatric Cancer Center, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
- Department of Neurosurgery, Shanghai General Hospital, Shanghai, China.
- Department of Neurosurgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
Zitieren
APA
Fei, X., Wu, J., Tian, H., Jiang, D., Chen, H., Yan, K., Wang, Y., Zhao, Y., Chen, H., Xie, X., Wang, Z., Zhu, W., & Huang, Q. (2024). Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements. Cancer Biomarkers, 41(1), 1-24. https://doi.org/10.3233/cbm-230486
Vancouver
Fei X, Wu J, Tian H, Jiang D, Chen H, Yan K, et al. Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements. Cancer Biomarkers. 2024;41(1):1-24. doi:10.3233/cbm-230486
BibTeX
@article{Fei2024,
author = {Fei, Xifeng and Wu, Jie and Tian, Haiyan and Jiang, Dongyi and Chen, Hanchun and Yan, Ke and Wang, Yuan and Zhao, Yaodong and Chen, Hua and Xie, Xiangtong and Wang, Zhimin and Zhu, Wenyu and Huang, Qiang},
title = {Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements},
journal = {Cancer Biomarkers},
year = {2024},
volume = {41},
number = {1},
pages = {1--24},
doi = {10.3233/cbm-230486}
}
EUVIMED